Proactive Investors - Run By Investors For Investors

VentriPoint Diagnostics to showcase its VMS Plus heart system at Milan conference

The event has nearly 4,000 healthcare professionals from over 90 countries around the world
VentriPoint Diagnostics to showcase its VMS Plus heart system at Milan conference
Ventripoint is a heart imaging tech group

Medtech group VentriPoint Diagnostics Ltd (CVE:VPT) will showcase its next-generation VMS Plus heart imaging system at EuroEcho 2018 in Milan.

With nearly 4,000 healthcare professionals from over 90 countries around the world, EuroEcho is one of the world's largest cardiovascular imaging congress.

READ: VentriPoint Diagnostics reports that its new approved heart technology being used by internationally renowned pediatric cardiologist

"We are excited to showcase our next-generation VMS+ System to the European market. We will have live scanning in the booth to provide the opportunity for hands-on use by the cardiology community," said Mehran Mehrtash, the vice-president, the worldwide distributor of sales at VentriPoint.

The next-generation system is designed to use Artificial Intelligence (AI) to assess the performance of all four chambers of the heart from standard 2D echo images.

Artificial Intelligence (AI) is the future of cardiac imaging and is transforming clinical outcomes, says the company.

The conference is in Milan, Italy and runs from December 5 to 7, providing hands-on demonstrations of the next-generation VMS+ System.

Contact Giles Gwinnett at [email protected]

Follow Giles on Twitter @Gile74

View full VPT profile View Profile

VentriPoint Diagnostics Ltd. Timeline

Related Articles

Weight loss
January 07 2019
A deal with Indian firm Zeon Lifesciences in January is the ninth deal the firm has secured for the weight loss product
PT exercises
December 19 2018
The Californian company is a bet on an industry that is in need of transformation
An illustration of Ozop's BLIF technique
March 30 2019
A key area of focus for the West Palm Beach, Florida, company is development of balloon lumbar interbody fusion (BLIF) technology
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use